A study looked at how rat liver cancer cells make a protein called alpha-fetoprotein (AFP). They cloned the cells to see how different clones made AFP. They found that the cells varied a lot in how much AFP they made, even more than expected from mutations. Some clones were more stable in making AFP than others. They tried to select for stable clones but found that stability was not perfect over time.